222 related articles for article (PubMed ID: 20375014)
1. Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3.
Adrover M; Pauwels K; Prigent S; de Chiara C; Xu Z; Chapuis C; Pastore A; Rezaei H
J Biol Chem; 2010 Jul; 285(27):21004-12. PubMed ID: 20375014
[TBL] [Abstract][Full Text] [Related]
2. Dual conformation of H2H3 domain of prion protein in mammalian cells.
Xu Z; Prigent S; Deslys JP; Rezaei H
J Biol Chem; 2011 Nov; 286(46):40060-8. PubMed ID: 21911495
[TBL] [Abstract][Full Text] [Related]
3. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
4. The oligomerization properties of prion protein are restricted to the H2H3 domain.
Chakroun N; Prigent S; Dreiss CA; Noinville S; Chapuis C; Fraternali F; Rezaei H
FASEB J; 2010 Sep; 24(9):3222-31. PubMed ID: 20410442
[TBL] [Abstract][Full Text] [Related]
5. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
[TBL] [Abstract][Full Text] [Related]
6. Pathological mutations H187R and E196K facilitate subdomain separation and prion protein conversion by destabilization of the native structure.
Hadži S; Ondračka A; Jerala R; Hafner-Bratkovič I
FASEB J; 2015 Mar; 29(3):882-93. PubMed ID: 25416551
[TBL] [Abstract][Full Text] [Related]
7. The peculiar nature of unfolding of the human prion protein.
Baskakov IV; Legname G; Gryczynski Z; Prusiner SB
Protein Sci; 2004 Mar; 13(3):586-95. PubMed ID: 14767078
[TBL] [Abstract][Full Text] [Related]
8. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
Dima RI; Thirumalai D
Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of prion protein assembly into amyloid.
Stöhr J; Weinmann N; Wille H; Kaimann T; Nagel-Steger L; Birkmann E; Panza G; Prusiner SB; Eigen M; Riesner D
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2409-14. PubMed ID: 18268326
[TBL] [Abstract][Full Text] [Related]
10. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
11. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
Cobb NJ; Apetri AC; Surewicz WK
J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
[TBL] [Abstract][Full Text] [Related]
12. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
13. Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.
Elmallah MI; Borgmeyer U; Betzel C; Redecke L
Prion; 2013; 7(5):404-11. PubMed ID: 24121542
[TBL] [Abstract][Full Text] [Related]
14. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
15. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
16. Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions.
Nyström S; Hammarström P
Sci Rep; 2015 May; 5():10101. PubMed ID: 25960067
[TBL] [Abstract][Full Text] [Related]
17. The presence of valine at residue 129 in human prion protein accelerates amyloid formation.
Baskakov I; Disterer P; Breydo L; Shaw M; Gill A; James W; Tahiri-Alaoui A
FEBS Lett; 2005 May; 579(12):2589-96. PubMed ID: 15862295
[TBL] [Abstract][Full Text] [Related]
18. Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.
Macedo B; Sant'Anna R; Navarro S; Cordeiro Y; Ventura S
Microb Cell Fact; 2015 Nov; 14():174. PubMed ID: 26536866
[TBL] [Abstract][Full Text] [Related]
19. Methionine oxidation perturbs the structural core of the prion protein and suggests a generic misfolding pathway.
Younan ND; Nadal RC; Davies P; Brown DR; Viles JH
J Biol Chem; 2012 Aug; 287(34):28263-75. PubMed ID: 22654104
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.
Rouget R; Sharma G; LeBlanc AC
J Biol Chem; 2015 Feb; 290(9):5759-71. PubMed ID: 25572400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
